These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 14737662

  • 1. Cyclic PNA-based compound directed against HIV-1 TAR RNA: modelling, liquid-phase synthesis and TAR binding.
    Depecker G, Patino N, Di Giorgio C, Terreux R, Cabrol-Bass D, Bailly C, Aubertin AM, Condom R.
    Org Biomol Chem; 2004 Jan 07; 2(1):74-9. PubMed ID: 14737662
    [Abstract] [Full Text] [Related]

  • 2. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
    Watrin M, Von Pelchrzim F, Dausse E, Schroeder R, Toulmé JJ.
    Biochemistry; 2009 Jul 07; 48(26):6278-84. PubMed ID: 19496624
    [Abstract] [Full Text] [Related]

  • 3. Binding of a dinuclear ruthenium(ii) complex to the TAR region of the HIV-AIDS viral RNA.
    Buck DP, Spillane CB, Collins JG, Keene FR.
    Mol Biosyst; 2008 Aug 07; 4(8):851-4. PubMed ID: 18633486
    [Abstract] [Full Text] [Related]

  • 4. Solid-phase synthesis and thermal denaturation study of cyclic PNAs targeting the HIV-1 TAR RNA loop.
    Upert G, Mehiri M, Di Giorgio A, Condom R, Patino N.
    Bioorg Med Chem Lett; 2007 Nov 01; 17(21):6026-30. PubMed ID: 17826994
    [Abstract] [Full Text] [Related]

  • 5. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
    Vo MN, Barany G, Rouzina I, Musier-Forsyth K.
    J Mol Biol; 2006 Oct 13; 363(1):244-61. PubMed ID: 16962137
    [Abstract] [Full Text] [Related]

  • 6. Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
    Bonnard V, Pascale L, Azoulay S, Di Giorgio A, Rogez-Kreuz C, Storck K, Clayette P, Patino N.
    Bioorg Med Chem; 2010 Nov 01; 18(21):7432-8. PubMed ID: 20889349
    [Abstract] [Full Text] [Related]

  • 7. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation.
    Terreux R, Pairot S, Cabrol-Bass D, Patino N, Condom R.
    J Mol Graph Model; 2001 Nov 01; 19(6):579-85, 614-5. PubMed ID: 11552687
    [Abstract] [Full Text] [Related]

  • 8. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E, Barroso-del Jesus A, Romero-López C, Berzal-Herranz A.
    Biol Chem; 2003 Mar 01; 384(3):343-50. PubMed ID: 12715885
    [Abstract] [Full Text] [Related]

  • 9. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.
    Kolb G, Reigadas S, Boiziau C, van Aerschot A, Arzumanov A, Gait MJ, Herdewijn P, Toulmé JJ.
    Biochemistry; 2005 Mar 01; 44(8):2926-33. PubMed ID: 15723535
    [Abstract] [Full Text] [Related]

  • 10. Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures.
    Boucard D, Toulmé JJ, Di Primo C.
    Biochemistry; 2006 Feb 07; 45(5):1518-24. PubMed ID: 16445294
    [Abstract] [Full Text] [Related]

  • 11. A cyclic PNA-based compound targeting domain IV of HCV IRES RNA inhibits in vitro IRES-dependent translation.
    Caldarelli SA, Mehiri M, Di Giorgio A, Martin A, Hantz O, Zoulim F, Terreux R, Condom R, Patino N.
    Bioorg Med Chem; 2005 Oct 15; 13(20):5700-9. PubMed ID: 16061387
    [Abstract] [Full Text] [Related]

  • 12. Slight sequence modifications unexpectedly alter the metal-dependency of a kissing-loop interaction.
    Ohuchi SP, Nakamura Y.
    Nucleic Acids Symp Ser (Oxf); 2007 Oct 15; (51):395-6. PubMed ID: 18029753
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.
    Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL.
    Chem Biol; 2006 Sep 15; 13(9):993-1000. PubMed ID: 16984889
    [Abstract] [Full Text] [Related]

  • 14. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S, Richer D, Bernacchi S, Decroly E, Vigne R, Ehresmann B, Ehresmann C, Paillart JC, Marquet R.
    J Mol Biol; 2005 Nov 18; 354(1):55-72. PubMed ID: 16236319
    [Abstract] [Full Text] [Related]

  • 15. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M, Xu Z, Tu P, Yu X, Xiao S, Yang M.
    Bioorg Med Chem Lett; 2004 May 17; 14(10):2585-8. PubMed ID: 15109657
    [Abstract] [Full Text] [Related]

  • 16. Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation.
    Dayie KT, Brodsky AS, Williamson JR.
    J Mol Biol; 2002 Mar 22; 317(2):263-78. PubMed ID: 11902842
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and cellular uptake of a fluorescently labeled cyclic PNA-based compound.
    Caldarelli S, Depecker G, Patino N, Di Giorgio A, Barouillet T, Doglio A, Condom R.
    Bioorg Med Chem Lett; 2004 Sep 06; 14(17):4435-8. PubMed ID: 15357967
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
    Yu X, Lin W, Pang R, Yang M.
    Eur J Med Chem; 2005 Sep 06; 40(9):831-9. PubMed ID: 15925430
    [Abstract] [Full Text] [Related]

  • 19. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E, Tripathi S, Chaubey B, Désiré J, Pandey VN, Décout JL.
    J Med Chem; 2004 Sep 23; 47(20):4806-9. PubMed ID: 15369382
    [Abstract] [Full Text] [Related]

  • 20. Spirocyclic helical compounds as binding agents for bulged RNA, including HIV-2 TAR.
    Xiao Z, Zhang N, Lin Y, Jones GB, Goldberg IH.
    Chem Commun (Camb); 2006 Nov 13; (42):4431-3. PubMed ID: 17057867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.